Milestone Scientific Inc. (MLSS)
| Bid | 1.02 |
| Market Cap | 85.87M |
| Revenue (ttm) | 8.63M |
| Net Income (ttm) | -4.71M |
| EPS (ttm) | -0.06 |
| PE Ratio (ttm) | -18.26 |
| Forward PE | -23.62 |
| Analyst | Hold |
| Ask | 1.07 |
| Volume | 256,807 |
| Avg. Volume (20D) | 74,331 |
| Open | 0.94 |
| Previous Close | 0.92 |
| Day's Range | 0.89 - 1.10 |
| 52-Week Range | 0.58 - 1.39 |
| Beta | 1.13 |
About MLSS
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a ...
Analyst Forecast
According to 1 analyst ratings, the average rating for MLSS stock is "Hold." The 12-month stock price forecast is $1.25, which is an increase of 14.09% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago · seekingalpha.com
Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call TranscriptMilestone Scientific Inc. (NYSE:MLSS ) Q3 2024 Earnings Call Transcript November 15, 2024 8:30 AM ET Company Participants David Waldman - Crescendo Communications, Investor Relations Arjan Haverhals -...